Perifosine in Treating Patients With Recurrent Prostate Cancer

Summary

Phase II trial to study the effectiveness of perifosine in treating patients who have recurrent prostate cancer. Drugs used in chemotherapy such as perifosine use different ways to stop tumor cells from dividing so they stop growing or die

Timeline

Start

2003-03

Primary completion

2009-01

Completion

2009-01

Outcome

Outcome not reported

Stopped: “Did not meet interim stopping criteria for continuation to the second stage.”

Drugs

Indications